Understanding ALK+ NSCLC caregivers’ psychosociological burden: insights from ESMO 2025
A collaborative poster by APLUSA and Takeda, presented at the European Society for Medical Oncology (ESMO) 2025 Congress.
APLUSA Stats App is Back Online!
At APLUSA, we know that in the pharmaceutical industry, every number matters. Whether you are...
Obesity in France: Evolving Care Pathways, Innovations, and Market Perspectives
Obesity has become a major public health issue in France. It currently affects more than 8 million...
Social Media Impact of the 66th ASH Annual Meeting & Exposition 2024
Digital, hemato-oncology, Social Media Listening, Oncology
The ASH Annual Meeting & Exposition 2024 took place from December 7th to 10th, 2024, in San Diego,...
Helping you understand the evolving treatment landscape in Breast Cancer
HER2+ Metastatic Breast Cancer
Breast cancer is a critical health issue affecting millions of women worldwide. October is Breast...
SOCIAL MEDIA IMPACT of the EHA 2024 Hybrid Congress
Digital, hemato-oncology, Social Media Listening, Oncology
The EHA 2024 (European Hematogoly Association) Hybrid Congress took place from June 13th to June...
SOCIAL MEDIA IMPACT of ASCO 2024
Digital, hemato-oncology, Social Media Listening, Oncology
The 2024 ASCO annual meeting took place from May 31st to June 4th, 2024, in Chicago, Il, USA. This...
What does MM mean to me? A special interview with DR. Christine MAÏ - APLUSA
AplusA News, Healthcare Industry, Syndicated Studies, hematology, MMActionMonth, Multiple Myeloma
Myeloma Action Month is held every year for the whole month of March to encourage individuals and...
Post ASH 23 webinar with Dr. Blin | Focus on DLBCL session
AplusA News, hemato-oncology, ASH, congress
Discover the transcription of our Post-ASH 23 webinar with Dr. BLIN, provides comprehensive...